Seroquel XR in Schizophrenia Relapse Prevention
NCT00990626 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1600
Last updated 2010-11-17
Summary
The purpose of the study is to determine whether the Seroquel XR treatment for 6 months improve the relapse prevention in schizophrenic outpatients
Conditions
- Schizophrenia Relapse Prevention
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Attila Németh · National Psychiatric Centre
-
Lilla Szabó · AstraZeneca Hungary MC
-
Tamás Bábel · AstraZeneca Hungary MC
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
Countries
- Hungary
Study Locations
More Related Trials
-
Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia
NCT00234377 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia
NCT01213836 ·Status: COMPLETED ·Phase: PHASE4
-
Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia
NCT00206128 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Extended Release Depression Symptoms
NCT00640562 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia
NCT01214135 ·Status: COMPLETED
-
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
NCT00600756 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel XR in Adults With Schizophrenia
NCT00852631 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
NCT00954122 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia
NCT00690365 ·Status: COMPLETED
-
Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment
NCT00758251 ·Status: COMPLETED
-
Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
NCT00326144 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia
NCT00934726 ·Status: COMPLETED
-
Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison
NCT00702676 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics
NCT00689325 ·Status: COMPLETED
-
General Practice Research Database Seroquel XR Safety Study
NCT01447082 ·Status: COMPLETED
-
Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder
NCT00892463 ·Status: COMPLETED ·Phase: PHASE4
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
NCT00329264 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)
NCT00779506 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
NCT00926393 ·Status: COMPLETED ·Phase: PHASE4
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
NCT00320268 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Index Episode in Patients With Bipolar Disorder Treated by Seroquel XR
NCT01029145 ·Status: COMPLETED
-
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
NCT00322595 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
NCT00351910 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme
NCT00921362 ·Status: COMPLETED
-
A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended
NCT00922090 ·Status: COMPLETED